Codetta Bio
Morrisville
About Codetta Bio
Codetta Bio is a life sciences company working on a novel multi-omic analysis platform based on digital spatial polymerase chain reaction (dsPCR) and digital spatial immuno polymerase chain reaction (dsIPCR) (dsiPCR). Its integrated reagent, hardware, and software platform enable multiplexed, multi-omic liquid biopsy and isolated DNA, RNA, and protein analyses. The company aims to provide the life sciences community with a simultaneous multi-omic dsPCR solution that will accelerate research and development of next-generation therapies, improving patient care and quality of life.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $29.3M
- Last round: Undisclosed (Jun 2024)
- Website: codettabio.com
Industries & Categories
Biotechnology, Clinical Trials, Product Research
Social Profiles
Canonical: https://fsome.com/organization/codetta-bio-125999 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.